Search Results 2321-2330 of 18889 for Relapse

  1. Mayo Clinic's Influence on Tobacco Addiction and Tobacco Policies Spans Across the Globe

    ... relapse compared to standard outpatient treatment. The team is also using nicotine-dependent zebrafish to study addiction and the biological effects of ...

  2. Clinical trials - Oncology (Medical)

    Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

  3. Recent findings and future directions in non-Hodgkin's lymphoma therapy - Mayo Clinic

    Ansell SM. Checkpoint blockade in lymphoma. Journal of Clinical Oncology. 2021;5:525. Ansell SM, et al. PD-1 blockade with nivolumab in relapsed or refractory ...

  4. Publications - Sungjune Kim, M.D., Ph.D. - Mayo Clinic

    Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma. Ther Adv Hematol. 2017 Apr; 8(4):129-138 ...

  5. Cancer Clinical Trials - Medical Professionals

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

  6. CAR-T cell therapy - Care at Mayo Clinic

    Mayo Clinic researchers link CAR-T cell aging to cancer relapse · Mayo Clinic Q&A: What should I know about today's chemotherapy? Mayo Clinic Q&A ...

  7. Pediatrics Clinical Trials - Medical Professionals

    Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

  8. Clinical trials - Oncology (Medical)

    NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

  9. Pediatrics Clinical Trials - Medical Professionals

    Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

  10. Hematology - Clinical trials

    Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis ...